Compare Bandhan Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.44
1.88
NAV
₹10.19
₹532.86
Fund Started
10 Nov 2025
04 Jun 1999
Fund Size
₹290.55 Cr
₹4323.29 Cr
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
10.34%
3 Year
-
24.62%
5 Year
-
15.30%
Equity
95.88%
97.38%
Cash
4.09%
2.55%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.34% |
Apollo Hospitals Enterprise Ltd. | 8.67% |
Divi's Laboratories Ltd. | 7.61% |
Max Healthcare Institute Ltd. | 6.92% |
Cipla Ltd. | 6.76% |
Dr. Reddy's Laboratories Ltd. | 5.92% |
JB Chemicals & Pharmaceuticals Ltd. | 4.57% |
Mankind Pharma Ltd. | 3.48% |
Ajanta Pharma Ltd. | 2.91% |
Aurobindo Pharma Ltd. | 2.87% |
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 Nov 2025
04 Jun 1999
